Hospitals & Clinics
-
Opportunity India Desk Jun 05, 2018 - 1 min readGlobal wearable brand Fitbit announced that it has shipped over one million units of its "FitBit Versa" smartwatch that was launched earlier this year, priced at Rs 19,999 and was made available for purchase in April. The health and fitness-focussed smartwatch that comes with a long battery life and a "female health tracking" feature that ...
-
Opportunity India Desk Jun 02, 2018 - 0 min readZydus Cadila has received the final nod from US drug regulator to market Doxycycline Hyclate capsules USP, antibiotic used for treating bacterial infections, Cadila Healthcare said today. It is a tetracycline antibiotic used for the treatment of a wide variety of bacterial infections, including those that cause acne. "This medication is also used for prophylaxis ...
-
Opportunity India Desk May 31, 2018 - 2 min readSmart Metabolic Anti-Aging Centre, a futuristic and preventive healthcare centre, based in Saket, is the latest addition to New Delhi's buzzing wellness and healthcare landscape. A unit of Gujarmal Modi Hospital and Research Centre (GMHRC), the anti-aging Centre is a first-of-its-kind metabolic and functional wellness clinic in India, focusing on reversing metabolic damage ...
-
Opportunity India Desk May 31, 2018 - 1 min readMumbai based Pharmacy company has announced the appointment of Nicholas Hart as the head of company's specialty business. Mr Hart joins as President of this division and will lead Lupin’s Specialty brand business growth strategy and profit and loss. With over 25 years of specialty business, strategic and commercial operations experience ...
-
Opportunity India Desk May 29, 2018 - 2 min readIndia’s second-leading healthcare chain, Fortis Healthcare has stated that its subsidiary Escort Heart Institute & Research Centre has been directed to deposit Rs 503.36 crore to Director General of Health Services within a month on account of unwarranted profit. Fortis said Escort Heart Institute & Research Centre (EHIRCL) had received an ...
-
Opportunity India Desk May 28, 2018 - 1 min readZydus Cadila has received final nod from the US health regulator to market Nystatin ointment and Omeprazole and Sodium Bicarbonate capsules. Nystatin ointment is used to treat fungal skin infections. Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin ...
-
Opportunity India Desk May 24, 2018 - 3 min readExposing GlaxoSmithKline’s (GSK) to huge 40% tax burden might hamper the sale of British pharma giant’s Indian consumer products division. The pharma company is exploring potential buyers open to a merger and share swap as part of the deal, two people in the know said. 40% tax ...
-
Opportunity India Desk May 15, 2018 - 2 min readThe troubled drug-maker Orchid Pharma is suffering resistance from its lenders who have rejected the resolution plan of the bankrupt company, a decision that could push toward liquidation. “The resolution professional has conducted three rounds of bidding. However, lenders found bids in all the rounds unacceptable,” two senior persons who did ...
-
Opportunity India Desk May 14, 2018 - 1 min readPharma major Lupin has confirmed the completion of the inspection by US health regulator for its Nagpur facility without making any observations. In a BSE filing, Lupin "announced the successful completion of an inspection carried out by the United States Food and Drug Administration (USFDA) at its Nagpur facility. The inspection ...
-
Opportunity India Desk May 09, 2018 - 1 min readDrugmaker Strides Shasun Ltd has decided to merger Australian businesses with Apotex Inc, the company said in a stock-exchange disclosure. The transaction is subject to entering into definitive agreements, satisfactory due diligence, customary closing conditions and statutory approvals, Strides Shasun said. It didn’t disclose the deal value. The merged ...